4543.T
$2125.50
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.
Recent News
Terumo Record Q3 Highlights OrganOx Integration And Margin Story For Investors
Terumo (TSE:4543) reported record-high revenue and profit for its third quarter. North American demand and contributions from the recently acquired OrganOx business supported the result. The quarter also featured improved profit margins alongside the new revenue high. Terumo, a major medical technology group, is seeing its latest quarter shaped by hospital and procedure volumes, reimbursement trends, and ongoing demand for devices that support cardiovascular and surgical care. The record Q3...
Terumo Corp (TRUMF) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic Acquisitions ...
Despite challenges from tariffs and foreign exchange, Terumo Corp (TRUMF) achieves record-high revenue and operating profit, driven by strong North American demand and strategic acquisitions.
Okami raises $45M to commercialize vascular embolization devices
The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.
Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline
Terumo (TSE:4543) has recently caught the attention of investors following a sustained share price decline over the past month, with the stock down nearly 5% and extending to a 14% drop over the past 3 months. This pullback provides an interesting vantage point for those tracking trends in the healthcare sector. See our latest analysis for Terumo. Terumo’s recent pullback continues a broader downward trend, with the share price returning -20.87% year-to-date and the 1-year total shareholder...
US Shutdown End, FX, Earnings Nudge Asian Markets Higher
Asian stock markets were mixed on the high-side Thursday, as the US government shutdown ended, the y